Status:
COMPLETED
Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Diabetic Subjects With Hospital Stays
Eligibility:
All Genders
Brief Summary
In the context of the COVID-19 pandemic, a number of factors, including the lockdown that was imposed to limit the spread of infection, the fear of being contaminated during hospital consultations and...
Eligibility Criteria
Inclusion
- Diabetic subjects with hospital stays in France, 2017 to 2020.
Exclusion
- Absence of diabetes
Key Trial Info
Start Date :
October 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 14 2021
Estimated Enrollment :
3300000 Patients enrolled
Trial Details
Trial ID
NCT04891276
Start Date
October 16 2020
End Date
April 14 2021
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourogne
Dijon, France, 21000